Related Experiment Videos
Increase of serum tumor marker concentrations by interferon-alpha
1Department of Obstetrics and Gynecology, University of Erlangen-Nuremberg, Erlangen, Germany.
European Journal of Gynaecological Oncology
|September 23, 1998
Summary
Interferon-alpha injection in ovarian tumor patients showed a significant increase in CA125 levels in one early-stage ovarian cancer case. This suggests potential for earlier ovarian cancer detection by monitoring CA125 response to interferon-alpha.
Area of Science:
- Oncology
- Immunology
Background:
- Interferon-alpha (IFN-α) increases CA125 levels in ovarian cancer cells in vitro.
- CA125 is a tumor marker often elevated in ovarian cancer.
Purpose of the Study:
- To investigate if subcutaneous interferon-alpha injection can increase serum CA125 concentrations in patients with ovarian tumors.
- To explore the potential of interferon-alpha as a diagnostic tool for early ovarian cancer detection.
Main Methods:
- Nine patients with cystic ovarian tumors received 6 million IU of interferon-alpha subcutaneously.
- Serum levels of CA125, CA15-3, and CEA were monitored at defined intervals for three days post-injection.
Main Results:
- One patient with early-stage ovarian cancer (T1a N0 M0) and normal baseline CA125 showed a massive increase in CA125 three days after interferon-alpha injection.
- No significant increase in CA125 or other markers was observed in the remaining 8 patients (5 benign tumors, 3 ovarian cancers).
Conclusions:
- Interferon-alpha administration can induce a CA125 serum concentration increase in some patients with early ovarian cancer.
- This finding supports the hypothesis that interferon-alpha may facilitate earlier detection of ovarian cancer by monitoring CA125 response.